Penumbra Q1 2025 revenue $324.1M (+16.3% YoY); net income $39.2M; raises U.S. thrombectomy guidance

Penumbra Inc

2025-Q1 EPS reported $1.00 revenue$324,140,000

Revenue $324.1M (+16.3% YoY); U.S. Thrombectomy $187.9M (+25.0%).
Net income $39.2M; adjusted EBITDA $59.6M (18.4% margin).
Operating income $40.4M (12.4% margin); gross margin improved to 66.6% from 65.0%.
Raises U.S. Thrombectomy growth guidance to 20-21% YoY (from 19-20%); rev guidance reaffirmed $1.34-$1.36B.
International revenue down 2.5% YoY (-0.1% constant currency).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.